How to define reference intervals to rule in healthy individuals for clinical trials?

Author(s):
Elzen, W.P.J. den (0000-0002-6774-4077); Gerven, J. van; Schenk, P.W.; Boogaard, A.U. den; Kroon, R.; Klaassen, E.; Ballieux, B.E.P.B.; Cobbaert, C.M. (0000-0003-3565-1404)
Published
2017
Publication type
Article / Letter to editor
flagging ratesreference rangeselecting healthy volunteers for clinical trials
Date issued
2017-03-31
Language
English
Is part of
Clinical Chemistry and Laboratory Medicine (CCLM) (2017), Vol. 55, no. 3, p. E59-E61
hdl
1887/114550
doi
10.1515/cclm-2016-0307